These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36029536)

  • 21. Structure-Enabled Discovery of Novel Macrocyclic Inhibitors Targeting Glutaminase 1 Allosteric Binding Site.
    Xu X; Wang J; Wang M; Yuan X; Li L; Zhang C; Huang H; Jing T; Wang C; Tong C; Zhou L; Meng Y; Xu P; Kou J; Qiu Z; Li Z; Bian J
    J Med Chem; 2021 Apr; 64(8):4588-4611. PubMed ID: 33792311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and Characterization of a Fluorescent Probe for GLS1 and the Application for High-Throughput Screening of Allosteric Inhibitors.
    Xu X; Kuang Z; Han J; Meng Y; Li L; Luan H; Xu P; Wang J; Luo C; Ding H; Li Z; Bian J
    J Med Chem; 2019 Nov; 62(21):9642-9657. PubMed ID: 31603674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes.
    Matre P; Velez J; Jacamo R; Qi Y; Su X; Cai T; Chan SM; Lodi A; Sweeney SR; Ma H; Davis RE; Baran N; Haferlach T; Su X; Flores ER; Gonzalez D; Konoplev S; Samudio I; DiNardo C; Majeti R; Schimmer AD; Li W; Wang T; Tiziani S; Konopleva M
    Oncotarget; 2016 Nov; 7(48):79722-79735. PubMed ID: 27806325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circ-CREBBP promotes cell tumorigenesis and glutamine catabolism in glioma by regulating miR-375/glutaminase axis.
    Zhang L; Ye L; Xu Z; Jin Y; Song D
    Brain Res; 2022 Jan; 1775():147730. PubMed ID: 34813772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway.
    Li B; Cao Y; Meng G; Qian L; Xu T; Yan C; Luo O; Wang S; Wei J; Ding Y; Yu D
    EBioMedicine; 2019 Jan; 39():239-254. PubMed ID: 30555042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-137 inhibits glutamine catabolism and growth of malignant melanoma by targeting glutaminase.
    Luan W; Zhou Z; Zhu Y; Xia Y; Wang J; Xu B
    Biochem Biophys Res Commun; 2018 Jan; 495(1):46-52. PubMed ID: 29097210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting glutaminase 1 (GLS1) by small molecules for anticancer therapeutics.
    Chen Y; Tan L; Gao J; Lin C; Wu F; Li Y; Zhang J
    Eur J Med Chem; 2023 Apr; 252():115306. PubMed ID: 36996714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glutaminase inhibition as potential cancer therapeutics: current status and future applications.
    Cyriac R; Lee K
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2290911. PubMed ID: 38078371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferation.
    Qie S; Chu C; Li W; Wang C; Sang N
    J Cell Biochem; 2014 Mar; 115(3):498-509. PubMed ID: 24122876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual inhibition of glutaminase and carnitine palmitoyltransferase decreases growth and migration of glutaminase inhibition-resistant triple-negative breast cancer cells.
    Reis LMD; Adamoski D; Ornitz Oliveira Souza R; Rodrigues Ascenção CF; Sousa de Oliveira KR; Corrêa-da-Silva F; Malta de Sá Patroni F; Meira Dias M; Consonni SR; Mendes de Moraes-Vieira PM; Silber AM; Dias SMG
    J Biol Chem; 2019 Jun; 294(24):9342-9357. PubMed ID: 31040181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glutaminase 1 expression in colorectal cancer cells is induced by hypoxia and required for tumor growth, invasion, and metastatic colonization.
    Xiang L; Mou J; Shao B; Wei Y; Liang H; Takano N; Semenza GL; Xie G
    Cell Death Dis; 2019 Jan; 10(2):40. PubMed ID: 30674873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selenite inhibits glutamine metabolism and induces apoptosis by regulating GLS1 protein degradation via APC/C-CDH1 pathway in colorectal cancer cells.
    Zhao J; Zhou R; Hui K; Yang Y; Zhang Q; Ci Y; Shi L; Xu C; Huang F; Hu Y
    Oncotarget; 2017 Mar; 8(12):18832-18847. PubMed ID: 27902968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and biological evaluation of novel glutaminase 1 allosteric inhibitors with an alkane chain tail group.
    Chang X; Wang M; Zhang D; Zhang Y; Wang J; Li Z; Bian J; Xu X
    Eur J Med Chem; 2023 Jan; 246():115014. PubMed ID: 36525694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.
    Jacque N; Ronchetti AM; Larrue C; Meunier G; Birsen R; Willems L; Saland E; Decroocq J; Maciel TT; Lambert M; Poulain L; Hospital MA; Sujobert P; Joseph L; Chapuis N; Lacombe C; Moura IC; Demo S; Sarry JE; Recher C; Mayeux P; Tamburini J; Bouscary D
    Blood; 2015 Sep; 126(11):1346-56. PubMed ID: 26186940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer.
    Grinde MT; Hilmarsdottir B; Tunset HM; Henriksen IM; Kim J; Haugen MH; Rye MB; Mælandsmo GM; Moestue SA
    Breast Cancer Res; 2019 May; 21(1):61. PubMed ID: 31088535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the glutamine metabolism-related proteins glutaminase 1 and glutamate dehydrogenase in canine mammary tumours.
    Ryu JE; Park HK; Choi HJ; Lee HB; Lee HJ; Lee H; Yu ES; Son WC
    Vet Comp Oncol; 2018 Jun; 16(2):239-245. PubMed ID: 29266697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolomics-assisted discovery of a new anticancer GLS-1 inhibitor chemotype from a nortopsentin-inspired library: From phenotype screening to target identification.
    Carbone D; Vestuto V; Ferraro MR; Ciaglia T; Pecoraro C; Sommella E; Cascioferro S; Salviati E; Novi S; Tecce MF; Amodio G; Iraci N; Cirrincione G; Campiglia P; Diana P; Bertamino A; Parrino B; Ostacolo C
    Eur J Med Chem; 2022 Apr; 234():114233. PubMed ID: 35286926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutaminase 2 is a novel negative regulator of small GTPase Rac1 and mediates p53 function in suppressing metastasis.
    Zhang C; Liu J; Zhao Y; Yue X; Zhu Y; Wang X; Wu H; Blanco F; Li S; Bhanot G; Haffty BG; Hu W; Feng Z
    Elife; 2016 Jan; 5():e10727. PubMed ID: 26751560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure and activation mechanism of the human liver-type glutaminase GLS2.
    Ferreira IM; Quesñay JEN; Bastos AC; Rodrigues CT; Vollmar M; Krojer T; Strain-Damerell C; Burgess-Brown NA; von Delft F; Yue WW; Dias SM; Ambrosio AL
    Biochimie; 2021 Jun; 185():96-104. PubMed ID: 33746066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells.
    Lee YZ; Yang CW; Chang HY; Hsu HY; Chen IS; Chang HS; Lee CH; Lee JC; Kumar CR; Qiu YQ; Chao YS; Lee SJ
    Oncotarget; 2014 Aug; 5(15):6087-101. PubMed ID: 25026281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.